Search Results - "Shirakata, M."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Particle tracking study of the injection process with field interferences in a rapid cycling synchrotron by Shirakata, M. J., Fujimori, H., Irie, Y., Takayanagi, T.

    “…The large-bore magnets in the injection system of a high-intensity proton synchrotron are placed close to each other as compared to their bore sizes. In such…”
    Get full text
    Journal Article
  5. 5

    Replication licensing of the EBV oriP minichromosome by Hirai, K, Shirakata, M

    “…The latent EBV genome may persist in the integrated form as well as the circular episomal form. However, most of the latent viral DNA molecules are known to…”
    Get more information
    Journal Article
  6. 6

    Identification of Minimal oriP of Epstein-Barr Virus Required for DNA Replication by Shirakata, Masaki, Hirai, Kanji

    Published in Journal of biochemistry (Tokyo) (01-01-1998)
    “…DNA replication from oriP of Epstein-Barr virus is mediated by the virus replication factor EBNA1 and cellular factors and occurs approximately once in each…”
    Get full text
    Journal Article
  7. 7

    Dimerization specificity of myogenic helix-loop-helix DNA-binding factors directed by nonconserved hydrophilic residues by SHIRAKATA, M, FRIEDMAN, F. K, QIN WEI, PATERSON, B. M

    Published in Genes & development (01-12-1993)
    “…The myogenic regulatory factor MyoD dimerizes with other positive and negative regulatory factors through a conserved region called the helix-loop-helix (HLH)…”
    Get full text
    Journal Article
  8. 8

    bi-directional transcriptional promoters for the latency-relating transcripts of the pp38/pp24 mRNAs and the 1.8 kb-mRNA in the long inverted repeats of Marek's disease virus serotype 1 DNA are regulated by common promoter-specific enhancers by Shigekane, H, Kawaguchi, Y, Shirakata, M, Sakaguchi, M, Hirai, K

    Published in Archives of virology (01-01-1999)
    “…In cell lines established from Marek’s disease tumors, several viral transcripts are expressed and among them the products of pp38/pp24 mRNA and 1.8 kb-mRNA…”
    Get full text
    Journal Article
  9. 9

    Tumorigenicity of mouse BALB/c 3T3 fibroblast cells which express Epstein-Barr virus-encoded LMP1 and show normal growth phenotypes in vitro is correlated with loss of transforming growth factor-β1-mediated growth inhibition by Takanashi, M, Li, J, Shirakata, M, Mori, S, Hirai, K

    Published in Archives of virology (1999)
    “…Latent membrane protein 1 (LMP1) encoded by the Epstein-Barr virus (EBV) genome is known to induce loss of contact inhibition and the anchorage-independent…”
    Get full text
    Journal Article
  10. 10

    HMG1-related DNA-binding protein isolated with V-(D)-J recombination signal probes by SHIRAKATA, M, HÜPPI, K, USUDA, S, OKAZAKI, K, YOSHIDA, K, SAKANO, H

    Published in Molecular and Cellular Biology (01-09-1991)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  11. 11

    The E12 inhibitory domain prevents homodimer formation and facilitates selective heterodimerization with the MyoD family of gene regulatory factors by Shirakata, M., Paterson, B.M.

    Published in The EMBO journal (18-04-1995)
    “…Although the ubiquitous helix‐loop‐helix (HLH) protein E12 does not homodimerize efficiently, the myogenic factor MyoD forms an avid DNA‐binding heterodimer…”
    Get full text
    Journal Article
  12. 12

    Thermal neutron profile inside J-PARC main ring tunnel by Oyama, T., Hagiwara, M., Nakamura, H., Shirakata, M.J., Nagaguro, S., Yamazaki, H., Nishikawa, K., Sanami, T.

    “…To estimate the beam losses and activation in the J-PARC main ring (MR) tunnel, thermal neutron distribution was measured using gold foil activation detectors…”
    Get full text
    Journal Article
  13. 13

    Phosphorylation inhibits the DNA-binding activity of MyoD homodimers but not MyoD-E12 heterodimers by MITSUI, K, SHIRAKATA, M, PATERSON, B. M

    Published in The Journal of biological chemistry (15-11-1993)
    “…MyoD is a member of the basic helix-loop-helix (bHLH) family of muscle gene regulatory proteins that includes myogenin, myf-5, and MRF4. These proteins have…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Upstream regulatory region for inducible expression of the chicken skeletal myosin alkali light-chain gene by SHIRAKATA, M, NABESHIMA, Y.-I, KONISHI, K, FUJII-KURIYAMA, Y

    Published in Molecular and Cellular Biology (01-06-1988)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  16. 16

    Dok-1 and Dok-2 are negative regulators of T cell receptor signaling by Yasuda, Tomoharu, Bundo, Kenji, Hino, Ayako, Honda, Kazuho, Inoue, Akane, Shirakata, Masaki, Osawa, Mitsujiro, Tamura, Toshiki, Nariuchi, Hideo, Oda, Hideaki, Yamamoto, Tadashi, Yamanashi, Yuji

    Published in International immunology (01-04-2007)
    “…Interaction of the TCR complex with self- or foreign peptides is a central event in the immune responses. Upon TCR stimulation, a protein–tyrosine kinase…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Genes associated with immunoglobulin V(D)J recombination are linked on mouse chromosome 2 and human chromosome 11 by HUPPI, K, SIWARSKI, D, SHAUGHNESSY, J. JR, KLEMSZ, M. J, SHIRAKATA, M, MAKI, R, SAKANO, H

    Published in Immunogenetics (New York) (1993)
    “…The somatic rearrangement of DNA in antigen receptor genes, that is immunoglobulin (Ig) or T-cell receptor (Tcr), has proven to be one of the most potent…”
    Get full text
    Journal Article
  20. 20